Markets

Insider Trading

Hedge Funds

Retirement

Opinion

10 Stocks Market Experts are Talking About These Days

Page 1 of 5

In this article, we will take a detailed look at the 10 Stocks Market Experts are Talking About These Days.

Piper Sandler’s Chief Market Technician Craig Johnson said in a latest program on CNBC that despite the recent market volatility and “negative” headlines, he sees buying opportunities for long-term investors.

“The headlines out here are extremely negative all over the place and the sentiment toward this market is absolutely awful. Typically, you find these readings near sort of bear market lows, which is what you typically see. And if you also start to look at the VIX, it is elevated out here at this point in time. Now, technically we have broken some uptrends, we’ve closed below 50 and 200-day moving averages, but we’re getting to some pretty washed-out levels. I started looking at new highs, new lows, breadth indicators, and all these pieces. And we’re starting to get to levels where you look back and say, “Is this 1989? Is this a period of time that’s like the great financial crisis or the ’87 market crash?” And I think the answer to that is flat out no. So, we’re setting ourselves up for, I think, a potentially pretty good buying opportunity. All this negativity, and again, as Warren Buffett has said, you’ve got to be greedy when people are fearful. When people are greedy, and definitely a lot of fear out here, that seems to me to be a little bit misplaced on the charts.”

READ ALSO: 7 Best Stocks to Buy For Long-Term and 8 Cheap Jim Cramer Stocks to Invest In

For this article, we picked 10 stocks notable Wall Street analysts were discussing over the past few days. With each company we have mentioned the latest hedge fund sentiment. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

A person with a cell phone who is looking for new stocks

10. Invitation Homes Inc (NYSE:INVH)

Number of Hedge Funds Investors: 28

Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, said in a latest program on CNBC that he owns Invitation Homes Inc (NYSE:INVH) in his IRA account and believes the stock has a bright future:

“Dividend yield not high for a REIT, but I think it has a better growth story than most REITs. This is single-family rental homes. They have a portfolio of 80,000 homes in desirable suburban locations, mostly in the South and the West. It’s annualized at 8% a year total return for the last five years. So the dividend is important to that calculation, and the stock has really bided its time in this low 30s level. I think ultimately it breaks out when people feel better about the housing market and want to own REITs again.”

9. Live Nation Entertainment, Inc. (NYSE:LYV)

Number of Hedge Funds Investors: 44

Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, said in a latest program on CNBC that Live Nation Entertainment, Inc. (NYSE:LYV) is “extremely oversold.”

“Live Nation, okay, looking for support at the 50-day. Take a look at this, folks. This is a stock that has been on the list pretty much for the last six months. For the most part, it’s above its 200-day, but its RSI is completely washed out. Relative strength is down at 21 in trading, and we say around 30 is an oversold stock. So, this is extraordinarily oversold, down 11% on the year, down 12% in just the past week. But again, look at where it is relative to that support level, that 200-day. I think she could hold.”

Baron Focused Growth Fund stated the following regarding Live Nation Entertainment, Inc. (NYSE:LYV) in its Q4 2024 investor letter:

“In the fourth quarter, we initiated a new position in Live Nation Entertainment, Inc. (NYSE:LYV), the leader in the management and operation of live concerts at their owned and third-party venues. They are a leader in concert venue operations, tour promotions, event ticketing through Ticketmaster, and the selling of sponsorships and advertising on their website and owned venues. Live Nation’s dominant share in ticketing and unmatched scale in concert promotions are key competitive advantages for them and give them the ability to monetize tours through ticketing, sponsorships, and hig-margin food and beverage at their owned and operated venues. Concerts and live events are a secular growing business that we believe should grow at a high single-digit rate for the company as the industry grows and they take share. We believe the company has an opportunity to significantly increase pricing or add new supply given the continued consumer preference for experiences over goods and the scarce nature of these events. The company has an incredible brand, and benefits in both upcycles with strong demand, and downcycles through an increase in supply as touring is a significant part of artists’ incomes. Despite concerns about slower consumer spending growth from peak levels, the company continues to grow at a double-digit rate in revenue despite consumer worries and is now leaning in with increased marketing to grow internationally where it remains underpenetrated. The company is still generating strong cash flow with a robust balance sheet to fund venue renovations where it expects to generate 20% returns on capital. John Malone of Liberty Media still owns 30% of the business with the CEO owning a significant portion of his net worth in the stock. We believe valuation remains attractive at current levels given the double-digit growth we expect in both revenue and earnings over the coming years.”

8. Autozone, Inc. (NYSE:AZO)

Number of Hedge Funds Investors: 47

Joshua Brown of Ritholtz Wealth Management explained in a latest program on CNBC his bullish thesis for Autozone, Inc. (NYSE:AZO).

“This is not just recently one of the best stocks in the market — this is like a perennial All-Star. I wanted to highlight three names that are finding support at important trend lines because in this kind of market, if you want to buy strength, you should be buying strength intelligently. AZO is up 10% year to date. It’s only 5% below its 52-week high. Importantly, it is finding strong support at its 50-day moving average, which you can see in blue right there. It’s got another level at the 200, which is not far below. This is an extremely profitable company with net margins of 14% and a 23 multiple, which is not terribly expensive. It’s expecting 3% earnings growth this year. I think it’ll find that support.”

Brown Advisors Global Leaders Strategy stated the following regarding AutoZone, Inc. (NYSE:AZO) in its Q4 2024 investor letter:

AutoZone, Inc. (NYSE:AZO) is the leading replacement automotive parts retailer and distributor in the US, servicing both the Do-it-Yourself (DIY) and Do-it-for-Me (DIFM) segments of the used car market, a market that is structurally growing as the fleet expands, with a high degree of visibility into future demand of the 6+ year used car cohort, which is AutoZone’s core target market. AutoZone is expanding into the faster growing DIFM market, as well as into Brazil and Mexico. The company’s superior customer outcome is immediate parts availability and the meaningful de-risking of the balance sheets of smaller garages which do not need to hold inventory themselves. It offers a differentiated service for customers based on local availability of parts (“in stock, in market”), quick turnaround speed and advice (including free specialty tool loans so DIY customers can complete necessary maintenance at lower cost but generating enduring loyalty). All this has historically proven difficult to replicate in an e-commerce setting. While there are a small number of large companies operating in this growing market, further consolidation of smaller competitors is expected as leading retailers’ scale (depth and breadth of inventory) and network effects (proximity to customers in immediate need of repair) constitute strong moats. One of the impressive characteristics of the company’s capital allocation is that it has delivered exceptional capital discipline and deployed its cash flow into share buybacks which has reduced the company’s share count by about 85% since 2000.”

7. Novo Nordisk A/S (NYSE:NVO)

Number of Hedge Funds Investors: 61

Jared Holz from Mizuho said in a latest program on CNBC that he thinks Novo Nordisk A/S (NYSE:NVO) selloff is overdone.

“It’s been horrifying to watch—it’s basically been cut in half since last summer. They had that big analyst day that excited the street, and now we’re sitting at multi-year lows. It feels fair and not fair. The news flow out of the company and the field has impacted it dramatically, so in some respects, yes. But they’re still going to grow 15 to 20% this year, and it’s a growth entity for the next few. When you compare it to some of the other names in pharma, it’s amazing. I was talking to some investors today, and I think the sentiment on Novo is the worst among all large-cap pharma.”

The analyst talked about the Street’s reaction to Novo Nordisk A/S (NYSE:NVO) weight-loss drug:

“They’re going to be the market leader. I still believe it’s a two-player market in this injectable market for the foreseeable future, if for no other reason than the cost involved—the manufacturing spend and all of those things. It’s interesting because the CagriSema data didn’t really excite the street, yet they’re excited about this Roche plus Zealand asset, which is essentially the same thing as CagriSema, but investors like it. So, I think we’ve kind of gone so far in terms of the pendulum swinging out of their favor that maybe you’re right, Karen—it’s time to buy a little bit.”

ClearBridge Large Cap Growth Strategy stated the following regarding Novo Nordisk A/S (NYSE:NVO) in its Q4 2024 investor letter:

“Similarly, we used a temporary price dislocation caused by disappointing clinical trial results to purchase shares of Novo Nordisk A/S (NYSE:NVO), a Danish-based leader in diabetes and obesity treatments. Novo’s Wegovy semaglutide drug was first to market among the new generation of obesity drugs; however, the company has lost market share to portfolio holding Eli Lilly due to delays in scaling up production volumes and superior weight loss results demonstrated by Lilly’s trizepatide drugs. While the initial market reaction to Novo’s more enhanced CagriSema weight loss treatment was negative, we believe this is a more potent formulation that can better compete with Lilly’s suite. With Novo poised to have a better product portfolio and improved supply position, we find the company’s valuation very attractive given the large secular growth trends behind the diabesity market.”

6. Intel Corporation (NASDAQ:INTC)

Number of Hedge Funds Investors: 68

Vivek Arya, Bank of America senior semiconductor analyst, said in a latest program on CNBC that the appointment of Lip-Bu Tan as new CEO was a very positive move by Intel Corporation (NASDAQ:INTC) and he’s hopeful of a turnaround at the company.

“I think this is a very smart move by Intel’s board. We think Lip-Bu brings a very fresh outsider’s perspective to the company. There are a lot of challenges ahead of them in trying to decide the right strategy for their manufacturing group and their product pipeline. You know, there still is no AI pipeline for the company. The manufacturing side is behind. But we think what Lip-Bu brings to the table is a broad expertise around the design side. He has worked well with foundries and was at Cadence Design Systems, so he knows how to work with external tools. At Cadence, he did a lot of restructuring, so I think he brings the right level of experience, knowledge, respect, and relationships across the supply chain. But we do think, you know, turnarounds don’t happen overnight. It takes a while to really manage something that is so asset-heavy. So we just think it’s a matter of time, but this is a very strong move.”

Invesco Growth and Income Fund stated the following regarding Intel Corporation (NASDAQ:INTC) in its Q3 2024 investor letter:

“Intel Corporation (NASDAQ:INTC): The chipmaker reported weaker-than-expected quarterly results as revenues declined and earnings were below expectations. Management also provided weaker guidance going forward; the stock fell on the news. We sold the position during the quarter.

The chipmaker’s quarterly earnings report was weaker than anticipated as revenues declined and earnings were below expectations. Management also provided weaker guidance going forward. Given that a potential recovery appears to be further in the future than we originally anticipated, we sold the position.”

5. Pfizer Inc (NYSE:PFE)

Number of Hedge Funds Investors: 92

Joshua Brown from Ritholtz Wealth Management recently talked about Pfizer during a program on CNBC. Here is what he said about the stock that is down 7% over the past 12 months:

“This is like the worst stock on earth. It stopped going down, interestingly. It’s not going up like a lot of healthcare stocks did from the start of this year. So I missed out on that rotation by literally owning the worst healthcare stock in the world. But 18 times trailing P/E, 10 times trailing EV to EBITDA. They’ve had huge earnings challenges because they bet the ranch on COVID, and that ship has sailed. They haven’t replaced it yet with a robust enough pipeline for people to start taking their estimates higher. But that’s, I think, how I get bailed out of this thing. I’m flat. I don’t want anyone to feel bad. I have much worse stocks. But just the way that this company is being treated by investors right now, it’s like a ghost. But I think ultimately this is the type of stock where when it does turn, it’ll move too fast to catch it. And so that’s what I’m positioned for.”

Page 1 of 5

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29.99, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.99.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…